Track the Apotea AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Apotea AB (publ) has recorded 21 public disclosures. Market capitalisation: €7.8bn. The latest transaction was filed on 28 July 2026 (Purchase). Among the most active insiders: Pär Svärdson. The full history is openly available.
21
Insider Decl.
n/a
Thresholds
€4m
20 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Apotea AB (publ) Buy (bullish), based on 2 analysts. Average price target: SEK 92.50.
37Σ signal
Buys €4mn/a Sells
Fundamental score
Ranked 14,580 of 28,896 companies
51.8
score / 100
Value
42
Quality
61
FCF yld1.5%
Earn yld2.9%
EV/EBITDA17.6x
ROE28%
Gross mgn27%
Net mgn3.2%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
40,000 shares@ €10.35290.0053% mcap100.0% of flowAktieISINISIN SE0023313762FI:A003R305-1
21 of 21 declarations
About Apotea AB (publ)
Apotea AB (publ) is a Swedish company focused on online sales of pharmaceuticals and health products. It is listed on the Stockholm Stock Exchange (XSTO).